Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men

NCT03767595 is registered in ClinicalTrials.gov with Uromedica as lead sponsor.

NCT NCT03767595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03767595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men
Lead sponsor
Uromedica
Phase
Not applicable
Overall status
Recruiting
Start date
February 19, 2019
Completion date
December 31, 2031
Enrollment
145 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

stress urinary incontinence